Ranolazine dihydrochloride - CAS# 95635-56-6 Size:Solid 10 mg Formula: C30H38ClN7O3

Formula: C30H38ClN7O3

RG1678 (R)

may warrant clinical trials to assess its potential in the treatment of different painful or inflammatory conditions

with the potential for producing some of estrogen's beneficial effects without producing its adverse effects

Smiles: CC1C[C@@]2(N)/C(=C\C)/[C@H](CC3NC(=O)C=CC2=3)C=1

Ranolazine dihydrochloride - CAS# 95635-56-6 Size:Solid 10 mg Formula: C30H38ClN7O3Ranolazine is an anti ischemic compound, which inhibits late sodium current that results in a reduction of Na+ dependent Ca2+ overload. Studies indicate that ATP production is shifted towards glucose oxidation by Ranolazine. This is due to the fact that more oxygen is required to phosphorylate the same amount of ATP during fatty acid oxidation than carbohydrate oxidation. These studies indicate that Ranolazine also inhibits oxygen consumption and